Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
reports
OKYO Pharma Limited Sponsored ADR (OKYO) Stock Price & Analysis
5 Followers
OKYO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.31 - $7.00
Previous Close$1.38
Volume42.03K
Average Volume (3M)694.82K
Market Cap
$37.52M
Enterprise Value$36.75M
Total Cash (Recent Filing)£633.63K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-3.2
Beta-0.31
Next Earnings
Aug 01, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding21,769,853
10 Day Avg. Volume725,573
30 Day Avg. Volume694,817
Standard Deviation0.15
R-Squared0.01
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-92.52
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
OKYO Pharma Limited Sponsored ADR News
OKYO FAQ
What was OKYO Pharma Limited Sponsored ADR’s price range in the past 12 months?
OKYO Pharma Limited Sponsored ADR lowest stock price was $1.31 and its highest was $7.00 in the past 12 months.
What is OKYO Pharma Limited Sponsored ADR’s market cap?
Currently, no data Available
When is OKYO Pharma Limited Sponsored ADR’s upcoming earnings report date?
OKYO Pharma Limited Sponsored ADR’s upcoming earnings report date is Aug 01, 2023 which is in 127 days.
How were OKYO Pharma Limited Sponsored ADR’s earnings last quarter?
OKYO Pharma Limited Sponsored ADR released its earnings results on Dec 30, 2022. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is OKYO Pharma Limited Sponsored ADR overvalued?
According to Wall Street analysts OKYO Pharma Limited Sponsored ADR’s price is currently Overvalued.
Does OKYO Pharma Limited Sponsored ADR pay dividends?
OKYO Pharma Limited Sponsored ADR does not currently pay dividends.
What is OKYO Pharma Limited Sponsored ADR’s EPS estimate?
OKYO Pharma Limited Sponsored ADR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OKYO Pharma Limited Sponsored ADR have?
OKYO Pharma Limited Sponsored ADR has 21,144,854 shares outstanding.
What happened to OKYO Pharma Limited Sponsored ADR’s price movement after its last earnings report?
OKYO Pharma Limited Sponsored ADR reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -13.182%.
Which hedge fund is a major shareholder of OKYO Pharma Limited Sponsored ADR?
Currently, no hedge funds are holding shares in OKYO
---
OKYO Pharma Limited Sponsored ADR Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
-363.91%
Trailing 12-Months
Asset Growth
-68.51%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
OKYO Pharma Limited Sponsored ADR
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
---
Aptamer Group Plc
―
Diurnal
―
Nucana
―
Tissue Regenix
―
Freeline Therapeutics Holdings
―
---